David L. Bouwman

2.3k total citations
61 papers, 1.8k citations indexed

About

David L. Bouwman is a scholar working on Surgery, Oncology and Cancer Research. According to data from OpenAlex, David L. Bouwman has authored 61 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 13 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in David L. Bouwman's work include Pancreatitis Pathology and Treatment (10 papers), Breast Lesions and Carcinomas (9 papers) and Breast Cancer Treatment Studies (9 papers). David L. Bouwman is often cited by papers focused on Pancreatitis Pathology and Treatment (10 papers), Breast Lesions and Carcinomas (9 papers) and Breast Cancer Treatment Studies (9 papers). David L. Bouwman collaborates with scholars based in United States and Canada. David L. Bouwman's co-authors include Donald W. Weaver, Aleodor A. Andea, Robert G. Wiencek, Tracie Wallis, Lisa A. Newman, Daniel W. Visscher, A J Walt, Kathryn A Carolin, Peter J. Littrup and Michael White and has published in prestigious journals such as Cancer, Radiology and Critical Care Medicine.

In The Last Decade

David L. Bouwman

60 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David L. Bouwman United States 24 694 572 483 372 260 61 1.8k
P. Sevelda Austria 26 723 1.0× 482 0.8× 906 1.9× 286 0.8× 304 1.2× 137 2.7k
Oreste Claudio Buonomo Italy 28 722 1.0× 508 0.9× 906 1.9× 295 0.8× 225 0.9× 145 2.2k
Antonio Piñero Spain 22 910 1.3× 340 0.6× 455 0.9× 286 0.8× 334 1.3× 150 2.0k
Christiane Matuschek Germany 23 390 0.6× 581 1.0× 600 1.2× 275 0.7× 441 1.7× 110 1.8k
D M Dent South Africa 23 815 1.2× 591 1.0× 442 0.9× 596 1.6× 607 2.3× 75 2.1k
Heriberto Medina‐Franco Mexico 19 749 1.1× 377 0.7× 663 1.4× 357 1.0× 450 1.7× 113 1.8k
William Barrett United States 18 490 0.7× 332 0.6× 514 1.1× 279 0.8× 328 1.3× 63 1.4k
Kent C. Westbrook United States 25 1.3k 1.9× 750 1.3× 537 1.1× 564 1.5× 298 1.1× 59 2.2k
George Peros Greece 27 790 1.1× 355 0.6× 861 1.8× 352 0.9× 479 1.8× 76 2.0k
James L. Weese United States 26 936 1.3× 407 0.7× 1.3k 2.6× 250 0.7× 580 2.2× 94 2.4k

Countries citing papers authored by David L. Bouwman

Since Specialization
Citations

This map shows the geographic impact of David L. Bouwman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Bouwman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Bouwman more than expected).

Fields of papers citing papers by David L. Bouwman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Bouwman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Bouwman. The network helps show where David L. Bouwman may publish in the future.

Co-authorship network of co-authors of David L. Bouwman

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Bouwman. A scholar is included among the top collaborators of David L. Bouwman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Bouwman. David L. Bouwman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Seward, Shelly, Assaad Semaan, Aamer Qazi, et al.. (2013). EZH2 blockade by RNA interference inhibits growth of ovarian cancer by facilitating re-expression of p21waf1/cip1 and by inhibiting mutant p53. Cancer Letters. 336(1). 53–60. 25 indexed citations
3.
Semaan, Assaad, Aamer Qazi, Shelly Seward, et al.. (2011). MicroRNA-101 Inhibits Growth of Epithelial Ovarian Cancer by Relieving Chromatin-Mediated Transcriptional Repression of p21waf1/cip1. Pharmaceutical Research. 28(12). 3079–3090. 52 indexed citations
4.
Edelman, David A., Mark A. Mattos, & David L. Bouwman. (2010). FLS Skill Retention (Learning) in First Year Surgery Residents. Journal of Surgical Research. 163(1). 24–28. 54 indexed citations
5.
Littrup, Peter J., et al.. (2009). Cryotherapy for Breast Cancer: A Feasibility Study without Excision. Journal of Vascular and Interventional Radiology. 20(10). 1329–1341. 94 indexed citations
6.
Afonso, Nelia & David L. Bouwman. (2008). Lobular carcinoma in situ. European Journal of Cancer Prevention. 17(4). 312–316. 10 indexed citations
7.
Vishnubhotla, Priya, Laura Biernat, Lawrence E. Flaherty, et al.. (2006). A Phase II Study of Docetaxel, Doxorubicin, and Infusional 5-Fluorouracil in the Treatment of Patients With Locally Advanced Breast Cancer. American Journal of Clinical Oncology. 29(5). 484–489. 2 indexed citations
8.
Littrup, Peter J., Laurie Freeman‐Gibb, Aleodor A. Andea, et al.. (2005). Cryotherapy for Breast Fibroadenomas. Radiology. 234(1). 63–72. 94 indexed citations
9.
Andea, Aleodor A., David L. Bouwman, Tracie Wallis, & Lavinia P. Middleton. (2004). Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma. Breast Diseases A Year Book Quarterly. 15(3). 277–278. 41 indexed citations
10.
El-Rayes, B. F., Shadan Ali, Lance K. Heilbrun, et al.. (2003). Cytochrome p450 and glutathione transferase expression in human breast cancer.. PubMed. 9(5). 1705–9. 62 indexed citations
11.
Newman, Lisa A., Kathryn A Carolin, David L. Bouwman, et al.. (2002). Ethnicity related differences in the survival of young breast carcinoma patients. Cancer. 95(1). 21–27. 54 indexed citations
12.
Caleffi, Maira, Peter J. Littrup, Michael White, et al.. (2001). Ultrasound-guided cryoablation of breast flbroadenomas at four institutions using a 2.4-mm probe: 6-12 month follow up. Breast Cancer Research and Treatment. 69(3). 228. 9 indexed citations
13.
Dombi, George W., et al.. (1996). Thermostability of purified human pancreatic α-amylase is increased by the combination of Ca2+ and human serum albumin. Clinica Chimica Acta. 252(1). 11–20. 5 indexed citations
14.
Bouwman, David L.. (1993). The Management of Unexpected Findings at Surgery. Surgical Clinics of North America. 73(2). 203–212. 2 indexed citations
15.
Weaver, Donald W., Robert G. Wiencek, & David L. Bouwman. (1990). Percutaneous denver peritoneovenous shunt insertion. The American Journal of Surgery. 159(6). 600–601. 12 indexed citations
16.
Weaver, Donald W., et al.. (1989). Peritoneovenous shunt (PVS) for malignant ascites. An analysis of outcome.. PubMed. 55(7). 445–9. 15 indexed citations
17.
Bouwman, David L. & Donald W. Weaver. (1988). Colon Cancer: Surgical Therapy. Gastroenterology Clinics of North America. 17(4). 859–872. 5 indexed citations
18.
Weaver, Donald W., Robert G. Wiencek, David L. Bouwman, & A J Walt. (1987). Gastrojejunostomy: is it helpful for patients with pancreatic cancer?. PubMed. 102(4). 608–13. 139 indexed citations
19.
Missavage, Anne E., et al.. (1984). Hyperamylasemia after cardiopulmonary bypass.. PubMed. 50(6). 297–300. 10 indexed citations
20.
Sapala, M. Andrew, et al.. (1979). Cholelithiasis following subtotal gastric resection with truncal vagotomy.. Sight & sound/Sight and sound. 148(1). 32–8. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026